baber/WOPTO huggingface dataset:
Patent AU-736527-B2 (AU)
Title: Two-component packaged food products
Inventor: HAZELL NICHOLAS JOHN GERARD
IPC: A23P1/08
Filed: 1998-01-29
Granted: 2001-07-26
Abstract: The invention provides two-component shelf-stable packaged food products, especially packaged sauce products. The products comprise a container, a first food component filling a first region of the container, and a second food component filling a second region of the container, wherein the second food component either directly contacts the first food component or is separated therefrom by an edible interfacial layer. The second food component can be decanted off the first food component, and the second and first food components are adapted for use in combination in sequential food preparation steps. Preferably, the first food component is a thick sauce concentrate and the second food component is a vegetable oil containing chopped vegetable pieces. The vegetable oil and vegetable pieces are decanted and fried, prior to addition of the sauce concentrate, thereby achieving improved organoleptic properties.
Patent AU-760609-B2 (AU)
Title: Formulations for amylin agonist peptides
Inventor: ITALIAN JAMES L
IPC: A61K47/10
Filed: 1998-01-09
Granted: 2003-05-15
Abstract: The present invention is concerned with a pharmaceutical formulation in a container, for example, a vial, prefilled cartridge, prefilled syringe or disposable pen, comprising approximately 0.01 to about 0.5 % (w/v) amylin agonist, preferably pramlintide, in an aqueous system along with approximately 0.02 to about 0.5 % (w/v) of an acetate, phosphate, citrate, or glutamate buffer to a pH of the final composition of approximately 3.0 to about 6.0 as well as approximately 1.0 to 10 % (w/v) of a carbohydrate or polyhydric alcohol tonicifier; and, optionally, approximately 0.005 to 1.0 % (w/v) of a preservative selected from the group consisting of m-cresol, benzyl alcohol, parabens and phenol. These formulations maintain stability upon storage under refrigerated or room temperature conditions. Such formulations can be further combined with insulin in the same syringe for administration to a patient.
Patent AU-677982-B2 (AU)
Title: Agent for protecting technical materials, especially timber and timber materials
Inventor: METZNER WOLFGANG
IPC: A01N47/34
Filed: 1994-01-25
Granted: 1997-05-15
Abstract: The present invention relates to an agent for protecting technical materials, especially timber and timber materials, from damage or destruction by biological pests, especially timber-eating insects, based on at least one active insecticidal agent with at least one diluent or solvent and possibly at least one organic chemical binder, possibly at least one further agent and possibly other processing auxiliaries and additives, in which the active insecticidal agent (component I) is at least one benzoyl-urea compound of the general formula (1) and is contained in the agent mixed with a quantity generating a synergetic action of at least one triazole fungicide (component II). The present invention also relates to a process for protecting technical materials, especially timber and timber materials, from damage or destruction by biological pests, especially timber-eating insects, and the use of the timber protective agent of the invention.
Patent AU-674928-B2 (AU)
Title: Dispensing apparatus having a removable variable proportioning device
Inventor: SPRIGGS JOHN R
IPC: B01F13/00
Filed: 1994-01-06
Granted: 1997-01-16
Abstract: A system for diluting and dispensing concentrated liquid products is disclosed. The system includes a dispensing device (10, 150) containing a removable proportioning means such as an aspirator assembly (40, 154). A concentrate pickup tube (114) attaches to the dispensing device and is in fluid communication with the aspirator assembly. The dispensing device can utilize a rigid outlet tube (20, 159) which is removably attached to nozzle tip (18, 158) for dispensing to large containers. Also disclosed is a method for diluting and dispensing chemical solutions using the dispensing device of the invention.
Patent AU-686600-B2 (AU)
Title: LO-CD2a antibody and uses thereof for inhibiting T-cell activation and proliferation
Inventor: BAZIN HERVE
IPC: C07K16/28
Filed: 1994-03-04
Granted: 1998-02-12
Abstract: The present invention relates to an LO-CD2a antibody and methods of using such antibodies or molecules that bind to a portion of the same epitope (or a portion thereof) to prevent and inhibit an immune response in human patients, preferably, where the immune response is mediated by the activation and proliferation of T-cells or natural killer cells. The administration of an effective amou nt of the LO-CD2a antibody to a human patient will prevent or inhibit graft rejection, graft versus host disease or autoimmune disease.
Patent AU-626103-B2 (AU)
Title: Multilayer extrusion as process for making angioplasty balloons
Inventor: HAMLIN ROBERT N
IPC: B29C49/04
Filed: 1990-09-24
Granted: 1992-07-23
Abstract: A method of producing laminated inflatable, substantially inextensible expander members having composite properties enhancing their use on intravascular catheters, such as angioplasty catheters is described. Diverse polymeric compounds of differing properties are coextruded to create a multilayer parison (40). The parison (40) is subsequently drawn and expanded in a blow molding operation to yield an expander member exhibiting enhanced properties including lubricity, burst strength, limited radial expansion, bondability, and rupture characteristics.
Patent AU-633147-B2 (AU)
Title: Asynchronous optical communication system
IPC: H04B10/27
Filed: 1990-09-28
Granted: 1993-01-21
Abstract: Asynchronous optical time-division multiplexing communication system having: a central station (SN), terminal transmission circuits (UE), terminal reception circuits (UR), and broadcasting servers (BS), linked by optical links (UEL; URL; BL) to the central station. The central station consists of a spectrum-time switching optical device (SSTSN), a control means (CPU) and a synchronisation signal generator (CKU). The switching device (SSTSN) is linked optically to the terminal transmission circuits, to the terminal reception circuits, to the broadcasting servers and to circuits for configuration transmission (CE), for signalling transmission (SE), for configuration reception (CR), and for signalling reception (SR) of the control means. The synchronisation signal generator is linked by a first link (H1) to the switching device and by a second link (H2) to the control means (CPU) itself linked by a control link (CB) to the switching device (SSTSN). 
<??>The system uses in conjunction a first set of optical transmission frequencies (Fa) and a second set of optical control frequencies (Fb) for the switching. 
<IMAGE>
Patent AU-727292-B2 (AU)
Title: A device for optical connection of an optical fibre, with another optical element
Inventor: FOLDI PETER
IPC: G02B6/42
Filed: 1998-05-05
Granted: 2000-12-07
Abstract: A device for optical connection of an optical fibre (2) with a lens (4) comprises a substantially sleeve-shaped retainer (6) and a connector element (10). The optical fibre (2) is fixed in the retainer (6), and the retainer has an end surface (8) at which the end surface of the optical fibre is intended to be positioned. The connector element has an engagement surface (12) intended to engage the end surface of the retainer, said engagement surface being constituted by a funnel-shaped surface tapering from the end surface of the retainer. <IMAGE>
Patent AU-693786-B2 (AU)
Title: Pyridazines as interleukin-1beta converting enzyme inhibitors
Inventor: RINKER JAMES M
IPC: A61P35/00
Filed: 1994-06-07
Granted: 1998-07-09
Abstract: Disclosed are compounds of the formula (I) and pharmaceutically acceptable salts thereof: <CHEM>  wherein R1 is halogen, oxygen linked leaving group including aromatic ether, aromatic ester, alkyl sulfonate, aryl sulfonate, alkyl phosphonate, aryl phosphonate, alkyl phosphate or aryl phosphate; R2 is OR5, NH(CHR5)m-COOR5, NH(CHR5)mCON(R5)R6, N(R5)R6 or NH(CHR5)nOH;     R3 is H or alkyl;     R4 is H, substituted or unsubstituted aryl, heteroaryl or alkyl; R5 and R6 are independently H, lower alkyl, aryl, heteroaryl, aralkyl, heteroaralkyl or lower cycloalkyl;     m = 1-6; and     n = 2-6. pharmaceutical compositions containing the compounds; and a method for inhibiting interleukin-1 beta  protease activity in a mammal utilizing the compounds and compositions.
Patent AU-678467-B2 (AU)
Title: Novel sulfonylamino pyrimidines
Inventor: BREU VOLKER
IPC: C07D405/14
Filed: 1994-06-24
Granted: 1997-05-29
Abstract: Compounds of the formula <IMAGE> in which R<1> to R<9>, R<a>, R<b>, X, Y, Z, m and n have the meaning given in the description, can be used as medicines, in particular for the treatment and prophylaxis of conditions associated with endothelin activities.
Patent AU-725520-B2 (AU)
Title: Gasketed aerosol mounting cup
Inventor: ABPLANALP ROBERT H
IPC: B21D51/46
Filed: 1996-08-08
Granted: 2000-10-12
Abstract: An improved gasketed mounting cup for an aerosol container wherein the gasket is a folded-over and hinged sleeve gasket; said gasket being used as an alternative to the cut-type gasket. In the preferred version the hinge is distal to the body portion of the mounting cup. There is also provided a method for forming the improved gasketed mounting cup, as well as a novel punch for forming the folded-over or hinged gasket.
Patent AU-687816-B2 (AU)
Title: Compositions and methods for reparation and prevention of fibrotic lesions
Inventor: MARGOLIN SOLOMON B
IPC: A61P17/00
Filed: 1994-05-09
Granted: 1998-03-05
Abstract: In a preferred embodiment, drugs having pharmacological properties which are useful in the medicinal therapy of fibrotic disease for the reparation and prevention of fibrotic lesional tissues, such drugs including as active ingredient(s) one or more N-substituted 2-(1H) pyridone(s) and/or N-substituted 3-(1H) pyridones. The composition of this invention is novel as an anti-fibrotic drug, namely, as an agent for treating fibrosis. Any existing compounds have not been shown to be effective for the reparation and prevention of fibrotic lesions. The figure is a graphic representation of a response to a dosage of pirfenidone as shown in Table 3.
Patent AU-758761-B2 (AU)
Title: Guide roll
Inventor: MILBREDT MANFRED
IPC: B60B33/02
Filed: 2000-08-01
Granted: 2003-03-27
Abstract: A castor (1) has a securing device (V) for blocking running action and/or steering action of a wheel (2) mounted in a fork (3). A mounting of the fork (3) permits pivoting about a vertical axis (y-y). A push rod (11) operates an integrally formed combination part (K) located at the fork for providing functions of braking-blocking and/or steering blocking formation. The push rod (11) carries a plate (23) configured for interacting with fork-mounted steering-blocking and braking-blocking parts of the combination part (K), which has steering-blocking mating protrusions (25) and braking-blocking means (26), these being located in spaced-apart planes (E'-E', E''-E'').
Patent AU-728740-B2 (AU)
Title: Bottle for dispensing fluid, comprising a flexible bag, and method of manufacture
Inventor: BODIN JACQUES
IPC: B65D83/00
Filed: 1996-09-04
Granted: 2001-01-18
Abstract: PCT No. PCT/FR96/01350 Sec. 371 Date Apr. 30, 1997 Sec. 102(e) Date Apr. 30, 1997 PCT Filed Sep. 4, 1996 PCT Pub. No. WO97/09124 PCT Pub. Date Mar. 13, 1997Bottle for dispensing fluid comprising a rigid container including an opening with a neck and a separable base. A flexible bag intended to contain the product in fluid form is placed inside the container. The diameter of the neck of the flexible bag is greater than the diameter of the neck of the rigid container, and the neck of the bag has an external flange with a diameter greater than that of the bag and less than the inside diameter of the container. The flexible bag may be filled before or after assembly, and may be used in the dispensing of products in fluid form, especially in the pharmaceutical field.
Patent AU-666628-B2 (AU)
Title: Refiner segment
Inventor: VIRVING NILS
IPC: D21D1/38
Filed: 1994-05-02
Granted: 1996-02-15
Abstract: Refiner segments for use in disk refiners for the disintegration of lignocellulose-containing material are disclosed, in which the refiner segment is formed with a pattern of bars and grooves and includes dams placed in the grooves. The dams are arranged so that their angle in relation to the radius of the refiner segment is less than about 30 DEG , preferably less than about 15 DEG .
Patent AU-626490-B2 (AU)
Title: Neuroprotective 3-piperidino-4-hydroxychroman derivatives
Inventor: BUTLER TODD WILLIAM
IPC: C07D311/20
Filed: 1991-02-05
Granted: 1992-07-30
Abstract: 3-piperidino-4-hydroxychroman derivs. of formula (I) and their salts are new, where A and B = H or A with B = -CH2CH2-. X = CH2 or O. X1 = H or OH. Z = H, F, Cl, Br or OH. Z1 = H, F, Cl, Br or 1-3C alkyl. n = O or 1; m = 0 or 1-6. When X = 0 (I) pref has cis stereochemistry. (I) are prepd. by hydride redn. of a suitable alpha-aminoketone, using e.g. NaBH4 in THF at -15 to 15 deg.C.
Patent AU-679247-B2 (AU)
Title: Monoclonal antibodies against the alpha PDGF receptor and uses thereof
Inventor: LAROCHELLE WILLIAM J
IPC: C12R1/91
Filed: 1994-06-24
Granted: 1997-06-26
Abstract: Potent neutralizing monoclonal antibodies to the human  alpha  PDGF receptor ( alpha  PDGFR) and fragments thereof are described. These monoclonal antibodies specifically bind to an epitope on  alpha  PDGFR, inhibits PDGF binding with PDGF, antagonizes PDGF, and does not bind  beta  PDGFR receptor. A hybridoma cell line producing such a monoclonal antibody, methods of in vivo imaging of a pathological conditions and methods of inhibiting the growth of a neoplasia expressing  alpha  PDGFR, which use these monoclonal antibodies are also described. In vitro assays for detecting the presence of  alpha  PDGFR and for evaluating the binding affinity of a test compound are also described.
Patent AU-636719-B2 (AU)
Title: Optical test apparatus
IPC: G01M11/00
Filed: 1991-02-06
Granted: 1993-05-06
Abstract: PCT No. PCT/GB91/00183 Sec. 371 Date Oct. 14, 1992 Sec. 102(e) Date Oct. 14, 1992 PCT Filed Feb. 6, 1991 PCT Pub. No. WO91/12509 PCT Pub. Date Aug. 22, 1991.An optical test apparatus includes an optical time domain reflectometer for launching light pulses into a test fibre. An optical amplifier is provided in the light path between the optical time domain reflectometer and the test fibre or amplifying the light pulses. An optical switch is positioned in the light path between the amplifier and the test fibre for preventing light reaching the test fibre between the light pulses launched by the OTDR. Timing structure is provided for synchronising the operation of the optical switch so as to open the switch as a light pulse reaches the switch and close the switch as a light pulse leaves the switch.
Patent AU-593357-B2 (AU)
Title: Tetrahydrobenzothiazoles
Inventor: SCHNEIDER CLAUS
IPC: C07D277/82
Filed: 1987-06-22
Granted: 1990-02-08
Abstract: Compounds of the formula 
<IMAGE>
 (the substituents are defined in the description) can be obtained by customary methods. The novel compounds are suitable as active substances for medicaments.
Patent AU-608764-B2 (AU)
Title: N-alkylated quaternary nitrogen containing 5 membered heterocycles
Inventor: PARADIES HENRICH HASKO
IPC: C09K23/32
Filed: 1987-08-06
Granted: 1991-04-18
Abstract: The synthesis of quaternary five membered N-n-alkyl-heterocycles, especially of 4-hydroxy-N(1)-n-alkyl-imidazolium, 2,5-substituted N(3)-n-alkyl-thiazolium and substituted N(2) pyrazolium salts are described. The N-surfactants obtained have a very small critical micelle concentration (CMC) of 10-5-10-7 Mol/Liter, and are capable of forming micelles of different sizes and forms depending on the nature of the anions. The N-detergents can be used as pharmaceuticals.
Patent AU-729226-B2 (AU)
Title: Process for preparing flexible to semi-rigid polyurethane integral foams
Inventor: EISEN NORBERT
IPC: C08L75/04
Filed: 1998-05-08
Granted: 2001-01-25
Abstract: The invention provides a process for preparing flexible to semi-rigid polyurethane moulded items with compacted edge zones with given hardness and a much more flexible cellular core, so-called integral foams, in which physical blowing agents from the set comprising C6 hydrocarbons are used.
Patent AU-632421-B2 (AU)
Title: Ortho-substituted benzyl esters of cyclopropanecarboxylic acids
IPC: C07C69/753
Filed: 1991-05-30
Granted: 1992-12-24
Abstract: Ortho-substituted benzyl esters of cyclopropanecarboxylic acids I <IMAGE>  (X = N, CH> where A is one of the following cyclopropane radicals: <IMAGE> (R<1> is CN, C2-C8-alkyl, CF3, C3-C8-alkenyl, C1-C4-alkoxycarbonyl, optionally substituted phenyl-C1-C6-alkyl or phenyl-C3-C6-alkenyl, ethoxyphenyl, 2- or 3-bromophenyl, 2- or 4-trifluoromethylphenyl, 2,4- or 2,6-difluorophenyl, 2-fluoro-6-chlorophenyl, 2,4- or 2,6-dimethylphenyl, 2,3,6-trichlorophenyl, trimethylsilyl; R<2> is H or halogen; R<3> is optionally substituted phenyl; R<4> is CH3 or halogen; Hal is halogen),  with the proviso that X is CH when R<1> is CF3 or trimethylsilyl. The compounds I are suitable as fungicides and for controlling pests.
Patent AU-692476-B2 (AU)
Title: Method for spraying polymeric compositions with compressed fluids and enhanced atomization
Inventor: NIELSEN KENNETH ANDREW
IPC: B05D1/02
Filed: 1994-09-27
Granted: 1998-06-11
Abstract: The present invention is directed to methods for spraying polymeric compositions with supercritical or subcritical compressed fluids such as carbon dioxide or ethane over a wider range of spray conditions to provide improved spray application quality with reduced emission of solvent. The methods are accomplished by using an elongated spray orifice to transform narrow, fishtail, liquid-film sprays to wider, feathered, decompressive sprays.
Patent AU-777682-B2 (AU)
Title: Heart valve carrier and rinse cage
Inventor: PATHMANABAN LESLIE
IPC: A61F2/00
Filed: 2000-10-04
Granted: 2004-10-28
Abstract: A carrier for heart valves allows the removal of a heart valve from the carrier without manual manipulation. In addition, the carrier minimizes or substantially eliminates leaking of preserving fluid during transportation and storage. The carrier includes ajar, a rinse cage, and a holder to which a heart valve is attachable. The rinse cage includes a first engagement structure, for example, a channel, and the holder includes a second engagement structure, for example, a groove, complementary to the first engagement structure for releasably engaging therewith. A heart valve attached to the holder is disposed or suspended within the rinse cage when the engagement structures are engaged. A heart valve attached to the holder is protected not only when within the jar but also when removed from the jar. The holder has a socket for engaging with a surgical handle used to remove the valve from the jar for rinsing and implantation. The carrier may include apparatus for limiting rotation of the holder relative to the rinse cage and rotation of the rinse cage relative to the jar, which apparatus allows a surgical handle to be securely and firmly attached to the holder with essentially one hand and without removing the valve from the jar. The jar includes a lid that may have a rotatable gasket and a flange. The jar may have an apex-like top surface for making a compressive seal against the gasket when the lid is tightened. The flange may have a vent for allowing gases between the gasket and the lid to escape during sterilization processes of the carrier.
Patent AU-750971-B2 (AU)
Title: Faecal collector having breathable skin attachment means
Inventor: COLES PETER
IPC: A61F5/44
Filed: 1998-06-26
Granted: 2002-08-01
Abstract: The present invention relates to a faecal management device for babies, children or adults to be attached to the perianal area of the wearer. More particularly, the invention relates to an applicator for such a device (10). Claimed and described is an applicator (40), to be used in the placement of a faecal management device (10), said device (10) comprising a bag (11), said bag (11) having an aperture (21) and a flange (12) surrounding said aperture (21) for adhesive attachment to perianal area of a wearer, said applicator (40) comprising a handling portion (42); characterised in that said applicator (40) comprises at least two pressure points (42).
Patent AU-640268-B2 (AU)
Title: Controlled-environment medical container
IPC: F25D11/00
Filed: 1991-09-20
Granted: 1993-08-19
Abstract: A transport assembly which is particularly suitable for transporting medical material, particularly organs and tissues. The assembly includes a tissue container which includes a lid having a clamping assembly associated therewith for clamping an organ. In addition, a reservoir bag and collector bag are respectively connected to the tissue container, such that a physiological fluid can be pumped from the reservoir bag to the tissue container, and with fluid exiting the tissue container gathered in the collector bag. A support holder is also provided, and the support holder, tissue container, collector bag, and reservoir bag can be detachably placed in a box for transport.
Patent AU-555469-B2 (AU)
Title: Electrolytic reduction cell with linear baffle member on cell floor
Inventor: HUNI JEAN-PAUL ROBERT
IPC: C25C3/08
Filed: 1982-06-24
Granted: 1986-09-25
Abstract: An electrolytic reduction cell for the production of molten metal by electrolysis of a molten electrolyte, which is less dense than the molten metal includes a generally rectangular shell, one or more suspended anodes and a floor structure which supports a body of the molten metal. At least one essentially linear baffle member extends transversely of the cell and is formed with restricted flow channels for absorbing energy from the molten metal and to reduce the amplitude of the wave motion in the molten metal. The baffle may be in the form of a single member formed with apertures for metal flow restriction or may be constituted by a number of separate aligned members with metal flow channels between them.
Patent AU-741308-B2 (AU)
Title: Method and system for forming low-density polymer foam article
Inventor: HARFMANN WALTER R
IPC: B29C44/08
Filed: 1998-08-03
Granted: 2001-11-29
Abstract: A crystalline polymer resin, such as poly(ethylene terephthalate), is heated to melting. One or more blowing agents is selected wherein at least one of the blowing agents has a boiling point greater than the glass transition temperature for the resin and less than the forming temperature, such as the temperature of the mold used to form the useful article. The blowing agent(s) and resin are combined to create a mixture with a blowing agent concentration sufficient to produce a theoretical sheet foam density of less than 0.4 g/cm3. The mixture is cooled to a temperature approaching the freezing point of the mixture, and then extruded into a substantially uniform closed cell polymer foam sheet of density less than 0.4 g/cm3. The extruded sheet is then cooled by direct contact with a cooling surface at a surface temperature below the glass transition temperature such that the blowing agent(s) condenses and the sheet has a density of greater than 0.4 g/cm3 and a sheet crystallinity of less than 15%. An article is then formed from the cooled sheet by applying heat such that the condensed blowing agent(s) vaporizes and the article crystallizes at a density of less than 0.4 g/cm3 with a crystallinity of greater than 20%.